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Between January 1983 and December 1990, 20 patients aged80 years or older underwent valvular surgery. The patients'
ages varied from 80 to 87 years (mean, 82 ±1-5 years). The indication for operation was aortic stenosis in 19 patients, and
mitral insufficiency after previous mitral valve replacement with a bioprosthesis in one. There were 15 elective, two urgent,
and three emergency operations. Four of these patients had aortic valve replacement plus coronary artery bypass grafting.
Six patients (30%) had an uneventful hospital stay, and the other 14 (70%) experienced several post-operative compli-
cations. The operative mortality rate was 15% (three patients). All patients before operation were in NYHA (New York
Heart Association) class III and IV and all survivors remained in N YHA class I or II. The survivors have been followed
from 6 to 70 months (mean 20 ±8 months). The actuarial survival rate at 1 and 5 years was 78-5% and 67%, respectively.
Valvular replacement in octogenarians can be performed, despite the high rate of post-operative complications, with
increased but acceptable mortality. Long-term results are good.
Introduction
Symptomatic medical treatment may do little to improve
the condition of elderly patients with severe valvular heart
disease. Once the symptoms of congestive heart failure
develop, the quality of life deteriorates substantially111. In
the past, these individuals were not offered valve replace-
ment because of unacceptably high peri-operative mor-
tality and morbidity. Recently, percutaneous ballon aortic
valvuloplasty has emerged as an alternative to aortic valve
replacement for management of aortic stenosis'23'. In this
report, we assess the outcome of heart valve replacement
in octogenarians at the Clinic of Cardiovascular Surgery
of the University Hospital Zurich during a 7-year period.
Patients and methods
Between January 1983 and December 1990 20 patients
aged 80 years or older underwent valve replacement pro-
cedures at the Clinic of Cardiovascular Surgery of the
University Hospital, Zurich. All patients' records were
reviewed to assess age, sex, diagnosis, risk factors,
operative procedure, peri-operative complications, and
long-term follow-up. Cardiac catheterization and echo-
cardiography were performed in all patients. Narrowing
of the left main coronary artery by more than 50% and
narrowing of the other coronary arteries by more than
70% was considered sufficiently severe to warrant myo-
cardial revascularization. All operations were performed
with standard cardiopulmonary bypass in moderate
hypothermia with intermittent cold cardioplegia and
post-ischaemic warm blood cardioplegia since 1989.
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Data are presented as simple percentage and frequency
distributions. Values of con tinuousvariablesareexpressed
as mean ± the standard deviation. Survival curves were
calculated according to the method of Cutler-Ederer14'.
Results
A total of 20 patients underwent valve replacement
with or without coronary artery bypass grafting. One
patient had mitral valve replacement after previous mitral
valve replacement with a bioprosthesis, four had aortic
valve replacement plus coronary artery bypass grafting,
and 15 patients had aortic valve replacement alone. A
porcine heterograft was placed in 16 patients (11
Carpentier-Edwards, 3 Xeno-Medica, and 2 Ionescu-
Shiley valves) and a mechanical prosthesis in the other
four (three St. Jude Medical aortic, and one St. Jude
Medical mitral). Enlargement of the annular area by
Dacron patch was performed in four patients. Finally,
in two patients a resection of the asymetric septal
hypertrophy was performed.
Patients ages varied from 80 to 87 years (mean 82± 1-5
years). There were 11 women and nine men. All patients
had severe symptoms before operation that were refrac-
tory to aggressive medical therapy. All patients were
in NYHA functional class III or IV before operation.
Dyspnoea, angina, syncope, and heart failure were pres-
ent in 20, nine, seven and seven patients, respectively. Two
patients had a history of myocardial infarction, five
hypertension, one diabetes mellitus, one neurovascular
disease, three peripheral vascular disease, and one renal
failure.
There were 15 elective, two urgent and three emergency
operations. The indication for operation was aortic sten-
osis in 19 patients, and mitral insufficiency after previous
mitral valve replacement with a bioprosthesis in one
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NYHA (New York Heart Association) class
Figure 1 Bar graph of pre-operative ( • ) and postoperative (E9)
NYHA (New York Heart Association) functional classification.
patient. A mild aortic regurgitation was present in seven
patients, and a mild mitral regurgitation in nine.
Coronary artery disease was diagnosed in 11 cases: three-
vessel disease was found in three patients, two-vessel dis-
ease in four, and one-vessel disease in four patients. Left
ventricular ejection fraction was 52 ± 15% (range, 25 to
83%).
The mean aortic valve gradient was 70 ± 22 mmHg, the
calculated aortic area in patients with aortic stenosis was
0-5 ±015 cm2, pulmonary capillary wedge pressure was
20 ± 6 mmHg, and right atrial pressure 5 ± 2 mmHg. The
cardipulmonary bypass time was 84 + 33 min, and aortic
cross-clamp time was 52 + 22 min.
The operative mortality was 15% (three of 20 patients).
One patient with coronary artery disease and pre-
operative ejection fraction of 25% died from acute myo-
cardial infarction on the 6th post-operative day after an
initially uncomplicated course. Another patient with
asymptomatic 70% and 80% bilateral significant carotid
stenoses had developed cerebral insult and died from sep-
sis and multi-organ failure after aortic valve replacement
and coronary artery bypass grafting to the right coronary
artery. His ejection fraction was 31% pre-operatively.
The third patient with unsignificant coronary artery dis-
ease had post-operative bleeding with haemorrhagic
diathesis, he also died from acute myocardial infarction.
Six patients (30%) had an uneventful hospital stay, and
the others 14 (70%) experienced several post-operative
complications. Six patients had post-operative bleeding
and had to be re-operated for control of bleeding (two
patients twice). Ten patients had post-operative arrhyth-
mias; respiratory failure was observed in four, respiratory
infection in two, two patients developed a low cardiac
output syndrome. Delirium was noted in three, mental
confusion in one, and depression in one post-operatively.
Two patients had cerebrovascular accident, and two
sepsis. Three patients underwent tracheostomy and one
gastrostomy for chronic care after severe post-operative
complication.
At the end of follow-up (mean 22 months, range 6-70
months) all patients who survived were in NYHA func-
tional class I or II (Fig. I). All survivors had improved
compared to their pre-operative status. During follow-up
two patients died, one from myocardial infarction and the
other from sudden death. The 1-year and 5-year actuarial
survival rate was 78-5 ± 5 % and 67 ± 10% (Fig. 2).
Year
Figure 2 Actuarial survival of the whole group of 20 patients aged
80 years or older having valve replacement (the patients who died
in hospital are included), and of the age- and sex-matched counter-
parts in the general Swiss population. • = Swiss population; + =
postoperative.
Discussion
Our early mortality of 15% and 5-year actuarial sur-
vival rate of 67% showed an elevated but acceptable risk
in the octogenarian. Our report has confirmed the safety
and efficacy of valve replacement in this advanced age
group. Several studies have reported similar good results
in elderly patients undergoing cardiac surgery^12'. The
long-term survival curve of our patients is better than that
of the general population (Fig. 2).
The benefits of percutaneous aortic valvuloplasty in the
elderly are temporary, improving haemodynamic status
for a few weeks or months'13141; morbidity and mortality is
relatively high'15161. Percutaneous aortic valvuloplasty
may provide a modest inprovement of survival as com-
pared to the survival of untreated patients with significant
aortic stenosis'1416'. It is a palliative procedure for a popu-
lation of inoperable patients, but it is not an alternative to
valve replacement"2"14161.
The bioprosthetic valve is the safest cardiac valve
substitute in the octogenarian. Because systemic anti-
coagulation is rarely required, bioprostheses have a
reduced incidence of haemorrhagic and thrombotic
complications than mechanical valves'171.
Single-valve replacement combined with coronary
artery bypass grafting resulted in a higher early and late
mortality in octogenarians than in septuagenarians
undergoing similar combined procedures'3171. This
elevated mortality raises the question of the necessity of
concomitant revascularization during valve replacement
in the elderly. Conservatively, one may propose that, in
octogenarians, only those with critical coronary lesions
(>80%) or severe angina should undergo concomitant
coronary bypass grafting*51. The aggressive approach
requires prolonged ischaemic time and may not be appro-
priate in the octogenarian. This contrasts with the surgical
principle for younger patients in whom revascularization
should be performed at the time of valve replacement if
major coronary artery stenosis is present regardless of the
presence or absence of angina'181.
In two patients we performed a resection of the
asymmetric septal hypertrophy which had caused subval-
vular aortic stenosis. This clearly dynamic obstruction
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represents an adaptive mechanism to the long-standing
pressure or volume overload'19'. The policy of resection
during aortic valve replacement is radical in our centre.
In our experience it is safer to perform an immediate
operative resection of asymmetric septa! hypertrophy
than to rely on massive doses of beta-blockers during
periods of hypotension, which can occur when asym-
metric septal hypertrophy is left unrelieved during aortic
valve replacement'20'.
The operative risk is related to the procedure per-
formed, as well as to the degree of cerebrovascular, renal,
and respiratory impairment present pre-operatively*5-21'.
Our report also confirmed a high incidence of post-
operative complications in octogenarians. There is a
tendency for patients to either have no complications or
to have several together. The occurrence of pneumonia,
respiratory failure, or both is associated with a poor out-
come16'. The interpretation of these observations seems
clear: even in this generally healthy population of octo-
genarians, functional reserve is not great. A substantial
proportion of such patients have a prolonged and compli-
cated course, leading ultimately to a good outcome'51.
Early mortality in our study was closely related to poor
ventricular function and untreated concomitant diseases.
Healthy octogenarians with severe aortic stenosis and
good ventricular function should be considered as
potential candidates for a surgical intervention.
These patients should be further selected as having a
reasonable chance of surviving an operation. All con-
comitant diseases should be treated before or during the
valve replacement. Each case should be judged on an indi-
vidual basis, and decisions made by both the patient and
doctor.
Although the rate of post-operative complications is
high, heart valve replacement can be performed with
moderate mortality in relatively healthy octogenarians.
The improvement in functional capacity and the pro-
longation of late survival in our series justifies valve
replacement in selected octogenarian patients. Advanced
age itself should not be considered as a contraindication
to surgery.
The authors gratefully thank the assistance of Miss Anette Bauer
for help preparing the manuscript.
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